Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.

Care insights

See what’s changing now and why, within days of launch

How can we help?

Act as care happens, not months later

Monitor how drugs, devices, and guidelines are used in real-world care—from planning to early insights and ongoing trends.

first prescribing months stacked

Simulated cardiovascular therapy launch dashboard, modeled off a recent product launch post-FDA approval.

Uncover the clinical context behind trends

Map precise care pathways with granular EHR data

Characterize clinically eligible populations and map care before launch through ongoing use, with deep clinical data including labs, vitals, specialty pharmacy, dispensing data, device model numbers, and more.

Understand the “why” behind decisions with de-identified clinical notes

Refine messaging and improve medical affairs strategy by viewing the clinical reasoning, behavioral factors, and barriers shaping therapy uptake, switching, and discontinuation.

Note viewer of simulated cardiovascular therapy, with synthetic notes.

Turn market signals into launch momentum

Before launch

  • ^

    Confidently plan with a clear view of competitive dynamics, unmet needs, prescribing or usage behaviors, and patient journeys

  • ^

    Optimize brand messaging and investments

  • ^

    Precisely characterize eligible populations and map patient journeys

At launch

  • ^

    Access early patterns within days of launch

  • ^

    Understand the context behind early trends, including stopping and switching, through de-identified clinical notes

At launch

  • ^

    Monitor diagnoses, treatment patterns, and clinically relevant endpoints

  • ^

    Translate signals into faster course correction and stronger growth strategies

Improve patient outcomes at scale

For medical affairs teams, translate treatment insights into medical impact by highlighting evidence needs across relevant providers, care sites, and geographies.

Focus scientific engagement

Align KOL outreach with the evidence and treatment patterns affecting local clinical practice

Translate evidence into practice

Identify opportunities to connect with Truveta member health systems in support of research collaborations, medical education, and implementation science

Measure impact

Access population-level changes in care following scientific exchange

Insights for medical education. An example dashboard view showing patients with possible ATTR-CM who may benefit from but are not yet receiving therapy. Colored dots are aggregated by practitioner across the US

Additional resources

Stacked bar chart showing prior GLP-1 medication use among patients starting Foundayo, with 40.3% having no prior GLP-1 use and 22.5% previously using Zepbound.

Research

Access early trends on adoption

See some of the first research on orforglipron

Line chart showing amphetamine and dextroamphetamine prescription fill rates within 5, 10, and 30 days since 2020

Research

Respond when shortages impact care
Explore prescription and fill rates

Research

Close the gap between guidelines and real-world care
Pain management adherence for IUD insertion

Research

Target the barriers behind unequal access and outcomes
Precise barriers in pulmonary embolism treatment access and outcomes

Research

Act on the drivers of persistence, discontinuation, and reinitiation
Understanding GLP-1 adherence drivers